Concepedia

Stephane Litschig

SL

Statistics

Publications

4

Citations

746

H-Index

4

Active since

1999

Affiliations

Novartis (Switzerland)(Current)

Novartis (Germany)

Stephane Litschig is an author at Novartis (Switzerland) specializing in pharmacology, medicine, and pain management.

Publications per year

1999–2007

4

Publications

4

CPCCOEt, a Noncompetitive Metabotropic Glutamate Receptor 1 Antagonist, Inhibits Receptor Signaling Without Affecting Glutamate Binding

Stephane Litschig, F. Gasparini, D Rueegg et al. · Molecular Pharmacology · 1999 · 343 citations

Life Sciences, Neuroscience, Pharmacology +16

The Non-competitive Antagonists 2-Methyl-6-(phenylethynyl)pyridine and 7-Hydroxyiminocyclopropan[b]chromen-1a-carboxylic Acid Ethyl Ester Interact with Overlapping Binding Pockets in the Transmembrane Region of Group I Metabotropic Glutamate Receptors

Adriana Pagano, Doris Rüegg, Stephane Litschig et al. · Journal of Biological Chemistry · 2000 · 268 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Efficacy and tolerability of lumiracoxib 100 mg once daily in knee osteoarthritis: a 13-week, randomized, double-blind study vs. placebo and celecoxib

R. Lehmann, Marek Brzosko, Petr Kopsa et al. · Current Medical Research and Opinion · 2005 · 73 citations

Medicine, Orthopaedic Surgery, Pharmacotherapy +15

Lumiracoxib 400 mg once daily is comparable to indomethacin 50 mg three times daily for the treatment of acute flares of gout

R. Willburger, Eduardo Mysler, J. Derbot et al. · Lara D. Veeken · 2007 · 62 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

1–4 of 4